0001104659-26-025847
SEC filingValhi, Inc. reported a net loss attributable to stockholders of $57.6 million for fiscal year 2025, driven by a pre-tax loss of $43.0 million despite total revenues of $2.14 billion. The company generated $2.08 billion in net sales with $59.1 million in other income, but faced significant costs including $1.78 billion in cost of sales and $312.3 million in SG&A expenses. Key non-operating items included a $64.5 million gain from remeasuring the TiO2 joint venture investment and a $4.6 million gain from earn-out liability remeasurement. The balance sheet shows total assets of $2.63 billion with $1.36 billion in equity, while cash flow was negative across all activities: operating activities used $35.5 million, investing used $47.8 million (including $156.8 million for the TiO2 acquisition), and financing used $71.1 million. The company ended with $562.0 million in cash and equivalents.
Valhi, Inc. reported challenging financial results for fiscal year 2025, ending December 31, 2025. The company recorded a net loss of $54.9 million, which translated to a net loss attributable to Valhi stockholders of $57.6 million after accounting for $2.7 million in noncontrolling interest. This resulted in basic and diluted earnings per share of negative $2.00. Total revenues and other income reached $2.14 billion, consisting of $2.08 billion in net sales and $59.1 million in other income. However, total costs and expenses amounted to $2.18 billion, leading to an income loss before taxes of $43.0 million. The company paid $11.9 million in income tax expense despite the pre-tax loss.
The company's revenue performance was driven by $2.08 billion in net sales, representing the core operating revenue stream. Additional income of $59.1 million contributed to the total revenue figure of $2.14 billion. The document does not provide segment breakdowns, geographic mix, or specific growth drivers beyond these aggregate figures. No comparative prior period data is provided in the source material to calculate year-over-year changes or analyze revenue trends.
Cost of sales represented $1.78 billion of the company's expenses, while selling, general and administrative expenses totaled $312.3 million. Other significant expense components included $57.1 million in interest expense and $32.7 million in other components of net periodic pension and OPEB expense. The company recorded two substantial gains: $64.5 million from remeasuring the investment in the TiO2 manufacturing joint venture and $4.6 million from remeasuring an earn-out liability. These gains partially offset the operating losses but were insufficient to achieve profitability for the period.
Cash flow from operating activities was negative $35.5 million, primarily due to the net loss of $54.9 million, though partially offset by $66.4 million in depreciation and amortization. Investing activities used $47.8 million in cash, including $46.6 million in capital expenditures and $156.8 million for acquiring the remaining interest in the TiO2 manufacturing joint venture. Financing activities used $71.1 million, with significant borrowing activity offset by debt payments and dividends. The balance sheet shows total assets of $2.63 billion, including $1.26 billion in current assets and $751.6 million in net property and equipment. Total liabilities were $1.27 billion, with $590.9 million in long-term debt. Stockholders' equity stood at $1.02 billion for Valhi stockholders, with total equity of $1.36 billion including noncontrolling interests.
The provided document content does not include management guidance, strategic priorities, or specific risk factors that would typically appear in the Management Discussion & Analysis section of a 10-K filing. The XBRL financial data and document text focus exclusively on historical financial results without forward-looking statements or outlook commentary. Investors would need to consult the complete 10-K filing for management's perspective on future performance, strategic initiatives, and risk factors affecting the company.